Abstract

Research Article

Surgical and Delivery Outcomes of Coexisting Uterine Fibroids with Pregnancies in Nigeria

Ade-Ojo Idowu Pius* and Odetola Amoo A

Published: 19 March, 2024 | Volume 7 - Issue 1 | Pages: 037-041

Background: Coexisting uterine fibroid with pregnancy is associated with increased pregnancy complications. This study evaluates the prevalence of coexisting uterine fibroids, and surgical and delivery outcomes among pregnant women who had cesarean sections.
Methods: This comparative observational study was conducted among pregnant women who had cesarean sections at the labor ward operating room of Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria. One hundred and five pregnant women aged 20 years - 40 years were recruited and grouped based on the intraoperative presence of grossly visible uterine fibroids (n = 23) and no uterine fibroids (n = 82). Surgical and delivery outcomes were measured. Data were analyzed using IBM SPSS version 26 and the means between the two groups were compared using an independent sample t-test with significance set at p < .05.
Results: The prevalence of uterine fibroids found during cesarean sections in this study was 21.9%. The mean age of the participants was comparable (M = 30.25 SD = 5.232).  There were statistically significant differences in mean pre-operative packed cell volume (t(df) = 2.077 (65.31) p = .042, estimated blood loss (t(df) = 2.045 (36.664) p =.010, post-op packed cell volume 
(t(df) = 1.054 (24.035) p = .049, and duration of hospital stay (t(df) = -.235(65.846) p = .019. The study showed that there was a difference in mean surgery time = 7.996 95% CI: -.879 to 16.871 but this was not found to be statistically significant. 
Conclusion: Uterine fibroid coexisting with pregnancy has a significant effect on the surgery time, estimated blood loss, and length of hospital stay. Therefore, adequate complication readiness and proper follow-up of the patient will be crucial to avert likely complications during and after surgery in women with coexisting uterine fibroid in pregnancy.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001161 Cite this Article Read Full Article PDF

Keywords:

Uterine fibroids; Pregnancy; Surgical outcome; Delivery outcome

References

  1. Eze CU, Odumeru EA, Ochie K, Nwadike UI, Agwuna KK. Sonographic assessment of pregnancy co-existing with uterine leiomyoma in Owerri, Nigeria. Afr Health Sci. 2013 Jun;13(2):453-60. doi: 10.4314/ahs.v13i2.36. PMID: 24235949; PMCID: PMC3824468.
  2. Zhao R, Wang X, Zou L, Li G, Chen Y, Li C, Zhang W. Adverse obstetric outcomes in pregnant women with uterine fibroids in China: A multicenter survey involving 112,403 deliveries. PLoS One. 2017 Nov 14;12(11):e0187821. doi: 10.1371/journal.pone.0187821. PMID: 29136018; PMCID: PMC5685483.
  3. Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med. 2010 May;28(3):204-17. doi: 10.1055/s-0030-1251477. Epub 2010 Apr 22. PMID: 20414843; PMCID: PMC5330647.
  4. Moravek MB, Yin P, Ono M, Coon JS 5th, Dyson MT, Navarro A, Marsh EE, Chakravarti D, Kim JJ, Wei JJ, Bulun SE. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications. Hum Reprod Update. 2015 Jan-Feb;21(1):1-12. doi: 10.1093/humupd/dmu048. Epub 2014 Sep 8. PMID: 25205766; PMCID: PMC4255606.
  5. Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update. 2007 Sep-Oct;13(5):465-76. doi: 10.1093/humupd/dmm013. Epub 2007 Jun 21. PMID: 17584819.
  6. Plewka D, Marczyński J, Morek M, Bogunia E, Plewka A. Receptors of hypothalamic-pituitary-ovarian-axis hormone in uterine myomas. Biomed Res Int. 2014;2014:521313. doi: 10.1155/2014/521313. Epub 2014 Jun 22. PMID: 25050358; PMCID: PMC4090522.
  7. Wakabayashi A, Takeda T, Tsuiji K, Li B, Sakata M, Morishige K, Yaegashi N, Kimura T. Antiproliferative effect of adiponectin on rat uterine leiomyoma ELT-3 cells. Gynecol Endocrinol. 2011 Jan;27(1):33-8. doi: 10.3109/09513590.2010.487605. Epub 2010 May 26. PMID: 20504099.
  8. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 Jan;188(1):100-7. doi: 10.1067/mob.2003.99. PMID: 12548202.
  9. Wang X, Wang G, Han R, Gao M, Wang F, Hong Y, Chen Q. Uterine fibroids increase the risk of preterm birth and other adverse birth events: a systematic review and meta-analysis. Transl Pediatr. 2022 Jun;11(6):978-986. doi: 10.21037/tp-22-215. PMID: 35800281; PMCID: PMC9253953.
  10. Lee HJ, Norwitz ER, Shaw J. Contemporary management of fibroids in pregnancy. Rev Obstet Gynecol. 2010 Winter;3(1):20-7. PMID: 20508779; PMCID: PMC2876319.
  11. Vitale SG, Tropea A, Rossetti D, Carnelli M, Cianci A. Management of uterine leiomyomas in pregnancy: review of literature. Updates Surg. 2013 Sep;65(3):179-82. doi: 10.1007/s13304-013-0198-z. Epub 2013 Jan 30. PMID: 23361218.
  12. Krimou Y, Erraghay S, Guennoun A, Mamouni N, Bouchikhi C, Banani A. Myoma praevia and pregnancy. Pan Afr Med J. 2019 Jul 17;33:216. doi: 10.11604/pamj.2019.33.216.14898. PMID: 31692727; PMCID: PMC6814323.
  13. Morgan Ortiz F, Piña Romero B, Elorriaga García E, Báez Barraza J, Quevedo Castro E, Peraza Garay Fde J. Miomas uterinos durante el embarazo y su repercusión en el resultado obstétrico [Uterine leiomyomas during pregnancy and its impact on obstetric outcome]. Ginecol Obstet Mex. 2011 Aug;79(8):467-73. Spanish. PMID: 21966843.
  14. Qidwai GI, Caughey AB, Jacoby AF. Obstetric outcomes in women with sonographically identified uterine leiomyomata. Obstet Gynecol. 2006 Feb;107(2 Pt 1):376-82. doi: 10.1097/01.AOG.0000196806.25897.7c. PMID: 16449127.
  15. Cooper NP, Okolo S. Fibroids in pregnancy--common but poorly understood. Obstet Gynecol Surv. 2005 Feb;60(2):132-8. doi: 10.1097/01.ogx.0000154688.02423.68. PMID: 15671902.
  16. Egbe TO, Badjang TG, Tchounzou R, Egbe EN, Ngowe MN. Uterine fibroids in pregnancy: prevalence, clinical presentation, associated factors and outcomes at the Limbe and Buea Regional Hospitals, Cameroon: a cross-sectional study. BMC Res Notes. 2018 Dec 13;11(1):889. doi: 10.1186/s13104-018-4007-0. PMID: 30545402; PMCID: PMC6293543.
  17. Tîrnovanu MC, Lozneanu L, Tîrnovanu ŞD, Tîrnovanu VG, Onofriescu M, Ungureanu C, Toma BF, Cojocaru E. Uterine Fibroids and Pregnancy: A Review of the Challenges from a Romanian Tertiary Level Institution. Healthcare (Basel). 2022 May 6;10(5):855. doi: 10.3390/healthcare10050855. PMID: 35627994; PMCID: PMC9141014.
  18. Ani VC, Ogabido CA, Okpala BC. Coexisting fibroid in pregnancy and its labour outcome in Nigeria. World J Adv Res Rev. 2022 Oct 30 [cited 2023 Dec 12];16(1):844–850. https://wjarr.com/content/coexisting-fibroid-pregnancy-and-its-labour-outcome-nigeria
  19. Abam DS, Kasso T. Uterine fibroids and pregnancy: a review of the challenges. In: Abduljabbar HS, editor. Obstetrics. InTech; 2017 [cited 2023 Dec 12]. http://www.intechopen.com/books/obstetrics/uterine-fibroids-and-pregnancy-a-review-of-the-challenges
  20. Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. 2012 Mar 26;12:6. doi: 10.1186/1472-6874-12-6. PMID: 22448610; PMCID: PMC3342149.
  21. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008 Apr;198(4):357-66. doi: 10.1016/j.ajog.2007.12.039. PMID: 18395031.
  22. Parazzini F, Tozzi L, Bianchi S. Pregnancy outcome and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016 Jul;34:74-84. doi: 10.1016/j.bpobgyn.2015.11.017. Epub 2015 Nov 25. PMID: 26723475.
  23. Chen YH, Lin HC, Chen SF, Lin HC. Increased risk of preterm births among women with uterine leiomyoma: a nationwide population-based study. Hum Reprod. 2009 Dec;24(12):3049-56. doi: 10.1093/humrep/dep320. Epub 2009 Sep 9. PMID: 19740897.
  24. Jenabi E, Khazaei S, Masoumi SZ. The association between uterine leiomyoma and postpartum hemorrhage: a meta-analysis. CWHR. 2020 Sep 9 [cited 2023 Dec 12];16(4):259–264. https://www.eurekaselect.com/181125/article
  25. Zhao R, Wang X, Zou L, Zhang W. Outcomes of Myomectomy at the Time of Cesarean Section among Pregnant Women with Uterine Fibroids: A Retrospective Cohort Study. Biomed Res Int. 2019 Mar 10;2019:7576934. doi: 10.1155/2019/7576934. PMID: 30956984; PMCID: PMC6431434.
  26. Landman AJEMC, Don EE, Vissers G, Ket HCJ, Oudijk MA, de Groot CJM, Huirne JAF, de Boer MA. The risk of preterm birth in women with uterine fibroids: A systematic review and meta-analysis. PLoS One. 2022 Jun 2;17(6):e0269478. doi: 10.1371/journal.pone.0269478. PMID: 35653408; PMCID: PMC9162311.
  27. Sundermann AC, Aldridge TD, Hartmann KE, Jones SH, Torstenson ES, Edwards DRV. Uterine fibroids and risk of preterm birth by clinical subtypes: a prospective cohort study. BMC Pregnancy Childbirth. 2021 Aug 17;21(1):560. doi: 10.1186/s12884-021-03968-2. PMID: 34404387; PMCID: PMC8369624.
  28. Lam SJ, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome. Am J Obstet Gynecol. 2014 Oct;211(4):395.e1-5. doi: 10.1016/j.ajog.2014.03.066. Epub 2014 Apr 3. PMID: 24705132.
  29. Milazzo GN, Catalano A, Badia V, Mallozzi M, Caserta D. Myoma and myomectomy: Poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017 Dec;43(12):1789-1804. doi: 10.1111/jog.13437. Epub 2017 Sep 11. PMID: 28892210.
  30. Conti N, Tosti C, Pinzauti S, Tomaiuolo T, Cevenini G, Severi FM, Di Tommaso M, Petraglia F. Uterine fibroids affect pregnancy outcome in women over 30 years old: role of other risk factors. J Matern Fetal Neonatal Med. 2013 Apr;26(6):584-7. doi: 10.3109/14767058.2012.745504. Epub 2012 Nov 28. PMID: 23126572.

Figures:

Similar Articles

Recently Viewed

  • Antibacterial Screening of Lippia origanoides Essential Oil on Gram-negative Bacteria
    Rodrigo Marcelino Zacarias de Andrade, Bernardina de Paixão Santos, Roberson Matteus Fernandes Silva, Mateus Gonçalves Silva*, Igor de Sousa Oliveira, Sávio Benvindo Ferreira and Rafaelle Cavalcante Lira Rodrigo Marcelino Zacarias de Andrade, Bernardina de Paixão Santos, Roberson Matteus Fernandes Silva, Mateus Gonçalves Silva*, Igor de Sousa Oliveira, Sávio Benvindo Ferreira, Rafaelle Cavalcante Lira. Antibacterial Screening of Lippia origanoides Essential Oil on Gram-negative Bacteria. Arch Pharm Pharma Sci. 2024: doi: 10.29328/journal.apps.1001053; 8: 024-028.
  • Systemic Lupus Erythematosus and Depression Overview
    Ahmed Shaaban*, Nourelhouda Said and Hoda Afifi Ahmed Shaaban*,Nourelhouda Said,Hoda Afifi. Systemic Lupus Erythematosus and Depression Overview. Insights Depress Anxiety. 2024: doi: 10.29328/journal.ida.1001039; 8: 001-004
  • Cytotoxic Effects of Aminotriles with Bioactive Potential: An Integrative Review
    Paola da Costa Vieira, Lettícia Tenório Cavalcanti, Hélida Maravilha Dantas e Sousa Almeida and Igor de Sousa Oliveira and Sávio Benvindo Ferreira* Paola da Costa Vieira, Lettícia Tenório Cavalcanti, Hélida Maravilha Dantas e Sousa Almeida, Igor de Sousa Oliveira and Sávio Benvindo Ferreira*. Cytotoxic Effects of Aminotriles with Bioactive Potential: An Integrative Review. Arch Pharm Pharma Sci. 2023: doi: 10.29328/journal.apps.1001040; 7: 022-027
  • Design and optimization of mRNAs encoding an Anti-TIGIT antibody with therapeutic potential for cancer in TIGIT-humanized BALB/c Mice
    Jingmin Cui, Gulisaina Qiaerxie, Hui Qin, Feng Long, Xi Wang, Zhixin Yang, Peng Du* and Yong Cui* Jingmin Cui, Gulisaina Qiaerxie, Hui Qin, Feng Long, Xi Wang, Zhixin Yang, Peng Du*, Yong Cui*. Design and optimization of mRNAs encoding an Anti-TIGIT antibody with therapeutic potential for cancer in TIGIT-humanized BALB/c Mice. Arch Pharm Pharma Sci. 2023: doi: 10.29328/journal.apps.1001038; 7: 008-016
  • Autoimmune Diseases Associated with Iron Deficiency Anemia; Coexistence of Demyelinating Disease and Inflammatory Bowel Disease
    Hatice Hamarat*, Berrin Yalinbaş Kaya and Özlem Şahin Hatice Hamarat*, Berrin Yalinbaş Kaya, Özlem Şahin. Autoimmune Diseases Associated with Iron Deficiency Anemia; Coexistence of Demyelinating Disease and Inflammatory Bowel Disease. J Neurosci Neurol Disord. 2024: doi: 10.29328/journal.jnnd.1001089; 8: 008-009

Read More

Most Viewed

Read More

Help ?